FDA Drug recall D-0005-2025
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404,…
- FDA Drug
- Class I
- terminated
- Published 2024-10-09
On 2024-10-09 the FDA classified a Class I recall of Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404,… by Gilead Sciences, citing presence of Particulate Matter: Presence of glass particle.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0005-2025 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2024-09-19 |
| Published | 2024-10-09 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Gilead Sciences |
| Distribution | US |
Product
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Reason
Presence of Particulate Matter: Presence of glass particle.
Identifiers
| ndc | 61958-2902-2 |
|---|---|
| ndc | 61958-2901-2 |
| code_info | Lot: 47035CFA, Exp. 11/2025 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0005-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.